BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Pseudomonas infection
,
Hypothalamus
,
Avian flu virus
,
FOXP1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cetuximab
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
EGFR
MYOM2
NEUROG1
COLCA1
SLC25A48
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
RUIZ_TNC_TARGETS_DN
HINATA_NFKB_TARGETS_KERATINOCYTE_UP
WEI_MYCN_TARGETS_WITH_E_BOX
LEE_BMP2_TARGETS_DN
BERENJENO_TRANSFORMED_BY_RHOA_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Stage IV Triple Negative Breast Cancer treated with Cetuximab and Carboplatin
HNSCC PDX tumors of different molecular subtypes treated with cetuximab
Drug target sets for approved compounds
Gene expression in EGFR inhibitor resistant or sensitive pancreatic cancer
Cetuximab-sensitive and resistant head and neck cancer cell lines
Explore Curated Studies Results
Literature
Most Relevant Literature
Cetuximab every 2 weeks versus standard weekly dosing administration schedule.
Local ocular safety of the subconjunctival injection of cetuximab in rabbits.
Intraocular cetuximab: Safety and effect on axial elongation in young Guinea pigs with lens-induced …
Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuxim…
Premedication strategy in cetuximab rechallenge after Grade 2 hypersensitivity reactions.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Erlotinib in Combination With Cetuximab
Sirolimus and Cetuximab in Advanced Malignancies
Cetuximab Rechallenge Study
Cetuximab Monotherapy Maintenance Treatment in mCRC
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ